Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743
Bristol-Myers Squibb
Arnaud Scherpereel; Paul Baas; Anna K Nowak; Anne S Tsao; Nobukazu Fujimoto; Solange Peters; Aaron S Mansfield; Sanjay Popat; Yolanda Bautista Aragon; Toby Talbot; Francesco Grossi; Dariusz Kowalski; Muhammet A Kaplan; Andrés Felipe Cardona; Raheela Soomro; Nan Hu; Adam Lee; Virginia Ip; Yu-Han Hung; Gérard Zalcman